Actionnariat et activité des initiés pour Foghorn Therapeutics Inc. (FHTX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.17 |
| Capitalisation | $245M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-24 | Lynch Thomas J. Jr. | A-Award | 28,000 | $114K |
| 2026-06-24 | Duty Stuart | A-Award | 28,000 | $114K |
| 2026-06-24 | Biller Scott | A-Award | 28,000 | $114K |
| 2026-06-24 | Gallagher Neil | A-Award | 28,000 | $114K |
| 2026-06-24 | Mendelsohn Michael | A-Award | 28,000 | $114K |
| 2026-06-24 | SMITH IAN F | A-Award | 28,000 | $114K |
| 2026-06-24 | GILL SIMBA | A-Award | 28,000 | $114K |
| 2026-06-24 | PARSHALL B LYNNE | A-Award | 28,000 | $114K |
| 2026-06-24 | Cole Douglas G. | A-Award | 28,000 | $114K |
| 2026-04-10 | GOTTSCHALK ADRIAN | G-Gift | 59,208 |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $40.0M | $15.0M | $92.8M | $101.1M | $52.2M | $80.3M | $55.5M | $80.9M |
| Placements à Court Terme | 0 | 0 | $93.0M | $53.2M | $293.6M | $153.7M | $188.3M | $78.0M |
| Créances | 0 | 0 | 0 | $300.0M | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $40.4M | $16.9M | $190.7M | $459.6M | $351.4M | $240.2M | $249.6M | $163.2M |
| Immobilisations Corporelles | $2.1M | $3.7M | $62.3M | $56.1M | $49.4M | $42.9M | $32.6M | $32.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $43.1M | $22.3M | $255.6M | $519.8M | $404.9M | $285.9M | $284.0M | $198.1M |
| Dettes Fournisseurs | $2.0M | $3.4M | $3.7M | $3.8M | $5.4M | $6.3M | $3.8M | $4.3M |
| Dette à Court Terme | 0 | $4.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $3.5M | $12.7M | $18.8M | $48.7M | $55.2M | $58.4M | $67.0M | $59.7M |
| Dette à Long Terme | $7.0M | $11.0M | $19.7M | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $82.3M | $110.4M | $109.4M | $422.9M | $404.8M | $363.1M | $329.5M | $306.6M |
| Réserves | -$43.0M | -$94.1M | -$162.9M | -$264.3M | -$373.1M | -$471.6M | -$558.2M | -$632.5M |
| Capitaux Propres | -$39.3M | -$88.0M | $146.2M | $96.9M | $112000 | -$77.2M | -$45.5M | -$108.5M |
| Dette Totale | $7.0M | $16.6M | $82.0M | $58.3M | $51.5M | $45.1M | $37.1M | $41.3M |
| Dette Nette | -$33.0M | $1.6M | -$103.8M | -$96.0M | -$294.3M | -$189.0M | -$206.6M | -$117.6M |
| Fonds de Roulement | $36.9M | $4.2M | $171.8M | $410.9M | $296.2M | $181.7M | $182.6M | $103.5M |
Santé financière
| Dette / Capitaux propres | -0.53 |
| Ratio de liquidité | 3.36 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.39 |
Rentabilité
| Rentabilité des capitaux propres | 72.64% |
| Rentabilité du capital investi | -44.00% |
| Rentabilité des actifs | -31.75% |
| Marge brute | 42.73% |
| Marge opérationnelle | -186.38% |
| Marge nette | -175.78% |
Entreprises liées: ARCT · ASMB · ENTA · HUMA · IMRX · PYXS · SGMT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de FHTX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions